Insider Transactions in Q4 2021 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Michael L. Meyers SVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,900
+21.48%
|
$47,200
$8.77 P/Share
|
|
Dec 22
2021
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
24,000
-60.0%
|
$528,000
$22.01 P/Share
|
|
Dec 22
2021
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+37.5%
|
$168,000
$7.88 P/Share
|
|
Dec 20
2021
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
20,000
-55.56%
|
$420,000
$21.01 P/Share
|
|
Dec 20
2021
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+35.71%
|
$140,000
$7.08 P/Share
|
|
Dec 20
2021
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
61,000
-59.68%
|
$1,220,000
$20.29 P/Share
|
|
Dec 20
2021
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,000
+37.01%
|
$427,000
$7.58 P/Share
|
|
Dec 17
2021
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
35,156
-42.11%
|
$703,120
$20.0 P/Share
|
|
Dec 17
2021
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
35,156
+29.63%
|
$351,560
$10.9 P/Share
|
|
Dec 17
2021
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,676
-8.67%
|
$31,844
$19.02 P/Share
|
|
Dec 17
2021
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,676
+7.98%
|
$10,056
$6.38 P/Share
|
|
Dec 16
2021
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,715
-56.26%
|
$431,585
$19.08 P/Share
|
|
Dec 16
2021
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,715
+36.0%
|
$136,290
$6.38 P/Share
|
|
Dec 13
2021
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,609
-38.28%
|
$695,571
$19.05 P/Share
|
|
Dec 13
2021
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,609
+24.61%
|
$219,654
$6.79 P/Share
|
|
Nov 18
2021
|
Fabrice Egros |
SELL
Open market or private sale
|
Direct |
14,030
-23.43%
|
$252,540
$18.03 P/Share
|
|
Nov 18
2021
|
Fabrice Egros |
BUY
Exercise of conversion of derivative security
|
Direct |
14,030
+16.0%
|
$112,240
$8.41 P/Share
|
|
Oct 26
2021
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,296
-47.99%
|
$309,624
$19.2 P/Share
|
|
Oct 26
2021
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,296
+32.43%
|
$114,072
$7.2 P/Share
|
|
Oct 25
2021
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
44,704
-71.68%
|
$849,376
$19.13 P/Share
|
|
Oct 25
2021
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,704
+41.75%
|
$312,928
$7.2 P/Share
|
|
Oct 05
2021
|
Dennis Podlesak |
BUY
Other acquisition or disposition
|
Direct |
463
+1.05%
|
-
|